Jeffrey Jones to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Jeffrey Jones has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.141
-
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.
Score: 0.141
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.